SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
19-Mar-24 9:48 PM View: | Adma Biologics, Inc. (ADMA) | 19-Mar-24 | Sale | 411,829 | $6.08 | $2,503,920.00 | (16%) 2.6M to 2.19M | |
19-Mar-24 9:48 PM View: | Adma Biologics, Inc. (ADMA) | 18-Mar-24 | Private Sale | 49,887 | $6.01 | $299,821.00 | (2%) 2.65M to 2.6M | |
15-Mar-24 9:00 PM View: | Adma Biologics, Inc. (ADMA) | 15-Mar-24 | Sale | 183,008 | $6.01 | $1,099,880.00 | (6%) 2.84M to 2.65M | |
15-Mar-24 9:00 PM View: | Adma Biologics, Inc. (ADMA) | 14-Mar-24 | Sale | 448,276 | $6.05 | $2,712,070.00 | (14%) 3.29M to 2.84M | |
15-Mar-24 9:00 PM View: | Adma Biologics, Inc. (ADMA) | 13-Mar-24 | Private Sale | 407,000 | $6.21 | $2,527,470.00 | (11%) 3.69M to 3.29M | |
28-Feb-24 9:00 PM View: | Adma Biologics, Inc. (ADMA) | 26-Feb-24 | Grant | 24,040 | -- | -- | < 1% 3.67M to 3.69M | |
08-Mar-23 9:30 PM View: | Adma Biologics, Inc. (ADMA) | 06-Mar-23 | Grant | 25,815 | -- | -- | < 1% 3.64M to 3.67M | |
09-Mar-22 5:59 PM View: | Adma Biologics, Inc. (ADMA) | 07-Mar-22 | Grant | 26,586 | -- | -- | < 1% 3.62M to 3.64M | |
14-Jun-21 8:38 PM View: | Zosano Pharma Corp (ZSAN) | 10-Jun-21 | Grant | 15,000 | -- | -- | < 1% 2.73M to 2.74M | |
10-Jun-21 6:55 PM View: | Marker Therapeutics, Inc. (MRKR) | 08-Jun-21 | Grant | 12,658 | -- | -- | < 1% 3.16M to 3.17M | |
18-Mar-21 4:35 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase | 1,142,860 | $1.75 | $2,000,000.00 | 57% 2.02M to 3.16M | (100%) |
29-Jun-20 9:47 PM View: | Zosano Pharma Corp (ZSAN) | 25-Jun-20 | Grant | 7,500 | -- | -- | < 1% 2.72M to 2.73M | |
12-Feb-21 10:00 PM View: | Marker Therapeutics, Inc. (MRKR) | 19-May-20 | Grant | 17,022 | -- | -- | < 1% 2.0M to 2.02M | |
03-Mar-20 7:11 PM View: | Adma Biologics, Inc. (ADMA) | 28-Feb-20 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
15-Feb-19 9:09 AM View: | Loxo Oncology, Inc. (LOXO) | 15-Feb-19 | Disposition (change in control) | 2,038,920 | $235.00 | $479,145,984.00 | (50%) 4.08M to 2.04M | < 1% |
22-Apr-15 7:39 PM View: | Cidara Therapeutics, Inc. (CDTX) | 20-Apr-15 | Conversion | 351,518 | -- | -- | 50% 703.09K to 1.05M | |
04-Sep-14 8:28 PM View: | Ambit Biosciences Corporation (AMBI) | 02-Sep-14 | Exercise (in-the money or at-the-money) | 2,362 | $6.66 | $15,730.90 | < 1% 1.65M to 1.65M | |
06-Aug-14 4:11 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Conversion Duplicate | 2,850,710 | -- | -- | 1511% 188.71K to 3.04M | |
06-Aug-14 4:11 PM View: | Loxo Oncology, Inc. (LOXO) | 06-Aug-14 | Market Purchase Duplicate | 413,077 | $13.00 | $5,370,000.00 | 14% 3.04M to 3.45M | 1598% |
23-May-13 5:11 PM View: | Ambit Biosciences Corporation (AMBI) | 22-May-13 | Exercise (in-the money or at-the-money) | 103,712 | $0.02 | $2,489.09 | 7% 1.55M to 1.65M | |
21-May-13 7:45 PM View: | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Conversion | 1,122,590 | -- | -- | 512598% 0.22K to 1.12M | |
21-May-13 7:45 PM View: | Ambit Biosciences Corporation (AMBI) | 21-May-13 | Purchase | 423,635 | $8.00 | $3,389,080.00 | 38% 1.12M to 1.55M | |
18-Apr-12 5:11 PM View: | Golf Trust of America, Inc. (PTX) | 22-Mar-12 | Grant | 10,000 | -- | -- | < 1% 2.0M to 2.01M | |
15-Feb-12 7:15 PM View: | Adma Biologics, Inc. (ADMA) | 13-Feb-12 | Grant Duplicate | 2,516,860 | -- | -- | 100% 0 to 2.52M | |
12-Mar-10 12:51 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 10-Mar-10 | Private Sale | 2,090 | $16.15 | $33,753.50 | (100%) 2.09K to 0 | |
24-Feb-10 4:08 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 22-Feb-10 | Acquisition (other) | 2 | -- | -- | < 1% 2.03K to 2.03K | |
16-Feb-10 4:21 PM View: | MAP Pharmaceuticals, Inc. (MPLPE) | 11-Feb-10 | Disposition (other) | 2,088 | -- | -- | (50%) 4.18K to 2.09K |